AKYA - Akoya Biosciences, Inc.
IEX Last Trade
2.355
-0.015 -0.637%
Share volume: 5,276
Last Updated: Fri 27 Dec 2024 08:30:24 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$2.37
-0.02
-0.63%
Fundamental analysis
22%
Profitability
0%
Dept financing
21%
Liquidity
75%
Performance
30%
Performance
5 Days
4.24%
1 Month
14.95%
3 Months
-13.99%
6 Months
0.82%
1 Year
-52.05%
2 Year
-72.58%
Key data
Stock price
$2.36
DAY RANGE
$2.28 - $2.49
52 WEEK RANGE
$2.04 - $6.31
52 WEEK CHANGE
-$49.59
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
Company detail
CEO: Brian McKelligon
Region: US
Website: akoyabio.com
Employees: 90
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: akoyabio.com
Employees: 90
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Akoya Biosciences provides spatial biology solutions focused on transforming discovery and clinical research. It offers single-cell resolution with spatial context that provides a wealth of information to visualize tissue organization and disease pathology on a molecular level. The company also provides PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition.
Recent news